Ppd Development Lp
UEI ZANENSW6C665 · NC · subsidiary of Ppd Development Lp · SAM.gov record ↗
$-7.5M
FY2025 obligations
30
Contract awards
Nov 1, 2011
First action
Sep 23, 2025
Latest action
Obligations by agency
- General Services Administration$3K
- Department Of Defense$-53K
- Department Of Health And Human Services$-7.4M
Obligations by NAICS
Monthly obligations
Oct 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93024F00002 ↗ | EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL | National Institutes Of Health | 541714 | $8.7M | Aug 15, 2024 | Aug 14, 2026 |
| 75F40124C00134 ↗ | MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | Food And Drug Administration | 541720 | $0 | Sep 24, 2024 | Jul 19, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93024F00001 ↗ | NIAID CLINICAL SITE MONITORING (NCSM) | National Institutes Of Health | 541714 | $24.4M | Feb 1, 2024 | Jan 31, 2026 |
| 75N93024F00002 ↗ | EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL | National Institutes Of Health | 541714 | $8.7M | Aug 15, 2024 | Aug 14, 2026 |
| 75N93022C00014 ↗ | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | National Institutes Of Health | 541715 | $6.7M | Jun 30, 2022 | Jun 29, 2026 |
| 75N93022C00001 ↗ | REGULATORY MANAGEMENT CENTER (RMC) | National Institutes Of Health | 541714 | $2.9M | Nov 1, 2021 | Oct 31, 2025 |
| 75N93019F00131 ↗ | DAIDS ONSITE MONITORING FOR 1 PHASE III STUDY: A5300B/PHOENIX | National Institutes Of Health | 541711 | $892K | Apr 15, 2019 | Dec 14, 2025 |
| 75N95024F00001 ↗ | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. | National Institutes Of Health | 541715 | $302K | Jun 17, 2024 | Jun 16, 2029 |
| 75N95024F00001 ↗ | CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/08/2029. | National Institutes Of Health | 541715 | $185K | Apr 9, 2024 | Apr 8, 2029 |
| 75N93022F00001 ↗ | TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | National Institutes Of Health | 541715 | $183K | Jan 14, 2022 | Jan 13, 2026 |
| 75N95025F00001 ↗ | TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT. | National Institutes Of Health | 541715 | $5K | Dec 20, 2024 | Dec 19, 2025 |
| 47QRCA25DU259 ↗ | ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | Federal Acquisition Service | 541690 | $3K | Dec 17, 2024 | — |
| 75N95024F00001 ↗ | SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) | National Institutes Of Health | 541712 | $0 | Jul 8, 2016 | Jun 30, 2026 |
| 75A50124C00001 ↗ | BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Dec 15, 2023 | Sep 30, 2030 |
| 75N93023F00001 ↗ | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI | National Institutes Of Health | 541715 | $0 | Jun 29, 2023 | Oct 31, 2025 |
| 75A50123C00045 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE SECTION G.1 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER TO JILL JOHNSON. TALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. | Office Of Assistant Secretary For Preparedness And Response | 541715 | $0 | Sep 29, 2023 | Sep 28, 2029 |
| 75N95022D00020 ↗ | CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: 9/22/2022 - 9/21/2027. N02DA-22-1235. | National Institutes Of Health | 541715 | $0 | Sep 22, 2022 | — |
| HT001122D0040 ↗ | OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | Defense Health Agency | 541714 | $0 | Jun 20, 2022 | — |
| 75F40124C00134 ↗ | MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | Food And Drug Administration | 541720 | $0 | Sep 24, 2024 | Jul 19, 2027 |
| 75N93022D00017 ↗ | EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | National Institutes Of Health | 541715 | $0 | Jan 14, 2022 | — |
| 75N95022C00036 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TERMINATION FOR CONVENIENCE. CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES | National Institutes Of Health | 541990 | $0 | Sep 28, 2022 | May 15, 2025 |
| 75N95023D00011 ↗ | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE. | National Institutes Of Health | 541715 | $0 | Sep 1, 2023 | — |
| 75N95023F00001 ↗ | REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK ORDER 02. 09/15/2023 - 12/31/2024. | National Institutes Of Health | 541715 | $0 | Sep 15, 2023 | Dec 31, 2024 |
| HHSN272201200002C ↗ | REGULATORY MANAGEMENT CENTER | National Institutes Of Health | 541711 | $-338 | Nov 1, 2011 | Oct 31, 2021 |
| 75N92019C00005 ↗ | CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTCOMES FOR T4 RESEARCH WITHIN LOWER MIDDLE-INCOME COUNTRIES (HY-TREC) | National Institutes Of Health | 541990 | $-1K | Apr 25, 2019 | Jul 25, 2023 |
| W81XWH18F0195 ↗ | HIV COHORT STUDY | Defense Health Agency | 541712 | $-53K | Jun 13, 2018 | Oct 13, 2022 |
| HHSN272201200004C ↗ | NIAID DAIT CLINICAL SITE MONITORING CENTER | National Institutes Of Health | 541711 | $-165K | Dec 16, 2011 | Feb 22, 2023 |